Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Feb 15;88(4):1407–1410. doi: 10.1073/pnas.88.4.1407

Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.

J W Harris 1, L R Pohl 1, J L Martin 1, M W Anders 1
PMCID: PMC51027  PMID: 1996342

Abstract

Hydrochlorofluorocarbons (HCFCs) are being developed as substitutes for ozone-depleting chlorofluorocarbons (CFCs); because widespread human exposure to HCFCs may be expected, it is important to evaluate their toxicities thoroughly. Here we report studies on the bioactivation of the CFC substitute 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123) to an electrophilic intermediate that reacts covalently with liver proteins. HCFC-123 and its analog halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) were studied in rats by 19F NMR spectroscopy, and we found that a trifluoroacetylated lysine adduct was formed with liver proteins. Also, the pattern of proteins immunoreactive with hapten-specific anti-trifluoroacetylprotein antibodies was identical in livers of HCFC-123- and halothane-exposed rats. Because halothane causes an idiosyncratic, and sometimes fatal, hepatitis that is associated with an immune response against several trifluoroacetylated liver proteins, the present findings raise the possibility that humans exposed to HCFC-123 or structurally related HCFCs may be at risk of developing an immunologically mediated hepatitis.

Full text

PDF
1407

Images in this article

1408Image
on p.1408
1408Image
on p.1408

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Christ D. D., Kenna J. G., Kammerer W., Satoh H., Pohl L. R. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. Anesthesiology. 1988 Dec;69(6):833–838. doi: 10.1097/00000542-198812000-00006. [DOI] [PubMed] [Google Scholar]
  2. Gandolfi A. J., White R. D., Sipes I. G., Pohl L. R. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane. J Pharmacol Exp Ther. 1980 Sep;214(3):721–725. [PubMed] [Google Scholar]
  3. Kenna J. G., Neuberger J., Williams R. Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis. J Pharmacol Exp Ther. 1987 Aug;242(2):733–740. [PubMed] [Google Scholar]
  4. Kenna J. G., Satoh H., Christ D. D., Pohl L. R. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther. 1988 Jun;245(3):1103–1109. [PubMed] [Google Scholar]
  5. Longstreth J. Cutaneous malignant melanoma and ultraviolet radiation: a review. Cancer Metastasis Rev. 1988 Dec;7(4):321–333. doi: 10.1007/BF00051373. [DOI] [PubMed] [Google Scholar]
  6. Maiorino R. M., Gandolfi A. J., Sipes I. G. Gas-chromatographic method for the halothane metabolites, trifluoroacetic acid and bromide, in biological fluids. J Anal Toxicol. 1980 Sep-Oct;4(5):250–254. doi: 10.1093/jat/4.5.250. [DOI] [PubMed] [Google Scholar]
  7. Manzer L. E. The CFC-Ozone Issue: Progress on the Development of Alternatives to CFCs. Science. 1990 Jul 6;249(4964):31–35. doi: 10.1126/science.249.4964.31. [DOI] [PubMed] [Google Scholar]
  8. Monks T. J., Lau S. S. Reactive intermediates and their toxicological significance. Toxicology. 1988 Nov 14;52(1-2):1–53. doi: 10.1016/0300-483x(88)90195-3. [DOI] [PubMed] [Google Scholar]
  9. Nelson S. D., Pearson P. G. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol. 1990;30:169–195. doi: 10.1146/annurev.pa.30.040190.001125. [DOI] [PubMed] [Google Scholar]
  10. Pohl L. R., Kenna J. G., Satoh H., Christ D., Martin J. L. Neoantigens associated with halothane hepatitis. Drug Metab Rev. 1989;20(2-4):203–217. doi: 10.3109/03602538909103537. [DOI] [PubMed] [Google Scholar]
  11. Pohl L. R., Satoh H., Christ D. D., Kenna J. G. The immunologic and metabolic basis of drug hypersensitivities. Annu Rev Pharmacol Toxicol. 1988;28:367–387. doi: 10.1146/annurev.pa.28.040188.002055. [DOI] [PubMed] [Google Scholar]
  12. Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J Pharmacol Exp Ther. 1985 Jun;233(3):857–862. [PubMed] [Google Scholar]
  13. Satoh H., Martin B. M., Schulick A. H., Christ D. D., Kenna J. G., Pohl L. R. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci U S A. 1989 Jan;86(1):322–326. doi: 10.1073/pnas.86.1.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shen E. S., Garry V. F., Anders M. W. Effect of hypoxia on carbon tetrachloride hepatotoxicity. Biochem Pharmacol. 1982 Dec 1;31(23):3787–3793. doi: 10.1016/0006-2952(82)90294-5. [DOI] [PubMed] [Google Scholar]
  15. Sun J. D., Dent J. G. A new method for measuring covalent binding of chemicals to cellular macromolecules. Chem Biol Interact. 1980 Oct;32(1-2):41–61. doi: 10.1016/0009-2797(80)90067-8. [DOI] [PubMed] [Google Scholar]
  16. Taylor H. R., West S. K., Rosenthal F. S., Muñoz B., Newland H. S., Abbey H., Emmett E. A. Effect of ultraviolet radiation on cataract formation. N Engl J Med. 1988 Dec 1;319(22):1429–1433. doi: 10.1056/NEJM198812013192201. [DOI] [PubMed] [Google Scholar]
  17. Van Dyke R. A., Gandolf A. J. Studies on irreversible binding of radioactivity from (14C)halothane to rat hepatic microsomal lipids and protein. Drug Metab Dispos. 1974 Sep-Oct;2(5):469–476. [PubMed] [Google Scholar]
  18. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES